New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 2, 2013
09:08 EDTSTEMStemCells receives FDA authorization of IND for spinal cord injury
StemCells announced that the FDA has authorized the company's Investigational New Drug, or IND, application for clinical testing of the company's proprietary HuCNS-SC human neural stem cells as a treatment for spinal cord injury. As a first action under this IND, the company is working to open U.S. sites for its Phase I/II clinical trial for chronic spinal cord injury, which is currently underway in Switzerland and Canada.
News For STEM From The Last 14 Days
Check below for free stories on STEM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
08:05 EDTSTEMStemCells completes enrollment in spinal cord injury trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use